M. Gamberini

发表

Left ventricle remodeling in patients with β-thalassemia major. An emerging differential diagnosis with left ventricle noncompaction disease.

D. Mele, G. Benea, M. Lombardi, 2017, Clinical imaging.

Survival and Complications in Thalassemia

A. Cnaan, M. Cappellini, A. Piga, 2005, Annals of the New York Academy of Sciences.

Alpha and beta cell evaluation in patients with thalassaemia intermedia and iron overload.

B. Bagni, V. De Sanctis, C. Vullo, 1985, Postgraduate medical journal.

Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry

S. Volpato, E. Cassinerio, M. Cappellini, 2014, British journal of haematology.

Osteoporosis in β‐Thalassemia: Clinical and Genetic Aspects

R. Galanello, C. Borgna-Pignatti, M. Mottes, 2005 .

An Aγ-globin G->A gene polymorphism associated with β039 thalassemia globin gene and high fetal hemoglobin production

R. Gambari, M. Borgatti, I. Lampronti, 2017, BMC Medical Genetics.

Deep Learning Staging of Liver Iron Content From Multiecho MR Images

Filippo Cademartiri, V. Positano, M. Santarelli, 2022, Journal of magnetic resonance imaging : JMRI.

Multicentre study on prevalence of endocrine complications in thalassaemia major

S. Andò, M. Cisternino, G. D'Ascola, 1995, Clinical endocrinology.

National networking in rare diseases and reduction of cardiac burden in thalassemia major

V. Positano, A. Meloni, M. Midiri, 2021 .

The Close Link of Pancreatic Iron With Glucose Metabolism and With Cardiac Complications in Thalassemia Major: A Large, Multicenter Observational Study

V. Positano, A. Meloni, V. De Sanctis, 2020, Diabetes Care.

Relationship between uric acid levels and cardiometabolic findings in a large cohort of β-thalassemia major patients.

V. Positano, A. Meloni, C. Vassalle, 2018, Biomarkers in medicine.

Reproductive behaviour of families segregating for Cooley's anaemia before and after the availability of prenatal diagnosis.

I. Barrai, B. Anderson, M. Lucci, 1991, Journal of medical genetics.

Atrial Fibrillation in β-Thalassemia: Overview of Mechanism, Significance and Clinical Management

M. Bertini, C. Rapezzi, Stefano Clò, 2022, Biology.

The haemochromatosis mutations do not modify the clinical picture of thalassaemia major in patients regularly transfused and chelated

P. Pignatti, R. Micciolo, C. Bombieri, 1998, British journal of haematology.

Chelation Therapy and Bone Metabolism Markers in Thalassemia Major

V. De Sanctis, S. Marconi, M. Gamberini, 2006, Journal of pediatric endocrinology & metabolism : JPEM.

Final height and endocrine function in thalassaemia intermedia.

V. De Sanctis, M. Gamberini, A. Lauriola, 1998, Journal of pediatric endocrinology & metabolism : JPEM.

Leptin and ghrelin serum concentrations in thalassemia major and intermedia patients and normal subjects

M. Karimi, V. Caruso, H. Karamifar, 2010 .

Relationship between pancreatic iron overload, glucose metabolism and cardiac complications in sickle cell disease: An Italian multicentre study

Filippo Cademartiri, V. Positano, A. Meloni, 2022, European journal of haematology.

Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience

N. Napoli, I. Gagliardi, M. Zatelli, 2022, Calcified Tissue International.

Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.

V. De Sanctis, E. De Sanctis, M. Gamberini, 2008, Pediatric endocrinology reviews : PER.

A rare cause of heart failure in iron-overload thalassaemic patients-primary hypoparathyroidism.

V. De Sanctis, S. Brachi, M. Gamberini, 2008, Georgian medical news.

Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose

C. Agrati, L. De Franceschi, M. Caminati, 2022, Blood.

Beta‐thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria

L. Aliberti, I. Gagliardi, M. Bondanelli, 2022, British journal of haematology.

Osteoporosis in beta-thalassemia: Clinical and genetic aspects.

R. Galanello, C. Borgna-Pignatti, M. Mottes, 2005, Annals of the New York Academy of Sciences.

Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia

A. Piga, F. Longo, V. Caruso, 2022, Therapeutic advances in hematology.

Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection

S. Perrotta, M. Cappellini, L. De Franceschi, 2021, American journal of hematology.

Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine

C. Vullo, V. Sanctis, M. Gamberini, 1996, European Journal of Pediatrics.

recommendations from an international panel Management of chronic viral hepatitis in patients with thalassemia

G. Brittenham, M. Cappellini, G. Foster, 2013 .

Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel.

G. Brittenham, M. Cappellini, D. Prati, 2010, Blood.

Spermatozoal DNA damage in patients with B thalassaemia syndromes.

V. De Sanctis, M. Gamberini, M. Katz, 2008, Pediatric endocrinology reviews : PER.

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major.

A. Cnaan, M. Cappellini, A. Piga, 2006, Blood.

GH/IGF-1 axis in a large cohort of ß-thalassemia major adult patients: a cross-sectional study

L. Aliberti, I. Gagliardi, M. Bondanelli, 2022, Journal of Endocrinological Investigation.

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

A. Cnaan, M. Cappellini, A. Piga, 2004, Haematologica.

Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.

V. De Sanctis, M. Gamberini, G. Gilli, 2008, Pediatric endocrinology reviews : PER.

Survival and Disease Complications in Thalassemia Major

M. Cappellini, A. Piga, G. Verlato, 1998, Annals of the New York Academy of Sciences.

Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia

Filippo Cademartiri, V. Positano, A. Meloni, 2022, Journal of personalized medicine.

Cardiac complications and diabetes in thalassaemia major: a large historical multicentre study

V. Positano, M. Lombardi, L. Gulino, 2013, British journal of haematology.

Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin)

C. Scapoli, R. Gambari, M. Borgatti, 2021, medRxiv.

A validated cellular biobank for β-thalassemia

S. Rivella, R. Gambari, M. Borgatti, 2016, Journal of Translational Medicine.

Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia.

S. Perrotta, A. Piga, F. Longo, 2019, Blood.

Complications of thalassemia major and their treatment

C. Borgna-Pignatti, M. Gamberini, 2011, Expert review of hematology.

A validated cellular biobank for β-thalassemia

S. Rivella, R. Gambari, M. Borgatti, 2016, Journal of Translational Medicine.

Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major

M. Giganti, M. Bondanelli, M. Zatelli, 2019, Endocrine.

Paraplegia due to spinal cord compression by extramedullary erythropoietic tissue in a thalassaemia intermedia patient with gynecomastia secondary to cirrhosis: successful treatment with hydroxyurea.

V. De Sanctis, M. Gamberini, M. Fortini, 2004, Pediatric endocrinology reviews : PER.

Real‐life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET

B. Giorgi, G. Abbate, V. Caruso, 2016, European journal of haematology.

Overall and complication‐free survival in a large cohort of patients with β‐thalassemia major followed over 50 years

M. Cappellini, G. Graziadei, F. Bonetti, 2023, American journal of hematology.

Prevalence of hepatitis B and C in thalassemic children in Punjab

V. Caruso, V. Sanctis, M. Gamberini, 2007 .

Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center.

V. De Sanctis, M. Gamberini, G. Gilli, 2004, Pediatric Endocrinology Reviews: diabetes, nutrition, metabolism.

Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia.

R. Galanello, A. Piga, A. Cohen, 2002, Blood.

Left ventricular remodelling, and systolic and diastolic function in young adults with β thalassaemia major: a Doppler echocardiographic assessment and correlation with haematological data

G. Bosi, R. Crepaz, W. Pitscheider, 2003, Heart.

MRI multicentre prospective survey in thalassaemia major patients treated with deferasirox versus deferiprone and desferrioxamine

V. Positano, A. Meloni, A. Pepe, 2018, British journal of haematology.

Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial

F. Fagnoni, M. Gamberini, R. Reverberi, 2021, Transfusion.

Preliminary observations about assisted reproduction in thalassaemia.

V. De Sanctis, P. Negri, M. Gamberini, 1998, Journal of pediatric endocrinology & metabolism : JPEM.

Incidence of cancer and related deaths in hemoglobinopathies: A follow‐up of 4631 patients between 1970 and 2021

E. Cassinerio, G. Graziadei, F. Longo, 2022, Cancer.

Adrenal incidentaloma in thalassemia: a case report and literature review.

N. Prandini, E. Chiodi, M. Gamberini, 2011, Pediatric Endocrinology Reviews: diabetes, nutrition, metabolism.

The Link of Pancreatic Iron with Glucose Metabolism and Cardiac Iron in Thalassemia Intermedia: A Large, Multicenter Observational Study

Filippo Cademartiri, V. Positano, A. Meloni, 2021, Journal of clinical medicine.

Thrombotic risk in thalassemic patients.

D. Gemmati, V. De Sanctis, M. Gamberini, 1998, Journal of pediatric endocrinology & metabolism : JPEM.

The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network

V. Positano, A. Meloni, A. Pepe, 2018, Annals of Hematology.

Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients

V. Positano, A. Meloni, A. Pepe, 2015, American journal of hematology.

Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major

Filippo Cademartiri, V. Positano, A. Meloni, 2023, Diagnostics.

Biventricular Reference Values by Body Surface Area, Age, and Gender in a Large Cohort of Well‐Treated Thalassemia Major Patients Without Heart Damage Using a Multiparametric CMR Approach

V. Positano, G. Aquaro, L. Ait-Ali, 2020, Journal of magnetic resonance imaging : JMRI.

Healing of leg ulcers with hydroxyurea in thalassaemia intermedia patients with associated endocrine complications.

V. De Sanctis, M. Gamberini, M. Fortini, 2004, Pediatric endocrinology reviews : PER.

Crushed deferasirox film‐coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single‐arm, interventional phase 4 study (MIMAS)

P. Charoenkwan, V. Viprakasit, M. Izquierdo, 2022, American journal of hematology.

[Heavy metal! A case of severe iron overload and supraventricular arrhythmias in a thalassemia major patient].

M. Bertini, M. Malagù, M. Gamberini, 2022, Giornale italiano di cardiologia.

Prospective CMR Survey in Children With Thalassemia Major: Insights From a National Network.

V. Positano, A. Meloni, M. Midiri, 2020, JACC. Cardiovascular imaging.

Gender differences in the development of cardiac complications: a multicentre study in a large cohort of thalassaemia major patients to optimize the timing of cardiac follow‐up

A. Meloni, M. Midiri, A. Pepe, 2018, British journal of haematology.

The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major

M. Giganti, I. Gagliardi, M. Zatelli, 2022 .

Left ventricular remodeling, systolic function, and diastolic function in young adults with beta-thalassemia intermedia: a Doppler echocardiography study.

G. Bosi, R. Crepaz, W. Pitscheider, 2002, Chest.

LUSPATERCEPT DECREASES TRANSFUSION BURDEN AND LIVER IRON CONCENTRATION IN REGULARLY TRANSFUSED ADULTS WITH BETA-THALASSEMIA

S. Perrotta, A. Piga, V. Caruso, 2016 .

[Anomalies of the masticatory apparatus in beta-thalassemia. The present status after transfusion and iron-chelating therapy].

C. Orzincolo, P. N. Scutellari, M. Gamberini, 1994, La Radiologia medica.

Thalassaemia is paradoxically associated with a reduced risk of in‐hospital complications and mortality in COVID‐19: Data from an international registry

M. Cappellini, L. De Franceschi, I. Akin, 2022, Journal of cellular and molecular medicine.

The continuous glucose monitoring system (CGMS) in patients with beta-thalassemia major and impaired glucose homeostasis: preliminary results.

V. De Sanctis, M. Gamberini, P. Banin, 2008, Pediatric endocrinology reviews : PER.

Endocrine effects on heart function

M. Lombardi, A. Meloni, P. Cianciulli, 2012 .

Left ventricular global function index is associated with myocardial iron overload and heart failure in thalassemia major patients

Filippo Cademartiri, V. Positano, A. Meloni, 2023, The International Journal of Cardiovascular Imaging.

The impact of HCV chronic positivity and clearance on extrahepatic morbidity in thalassemia major patients: an observational study from MIOT Network.

Filippo Cademartiri, V. Positano, A. Meloni, 2023, European journal of internal medicine.

Luspatercept (ACE-536) Reduces Disease Burden, Including Anemia, Iron Overload, and Leg Ulcers, in Adults with Beta-Thalassemia: Results from a Phase 2 Study

S. Perrotta, A. Piga, V. Caruso, 2015 .

Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients.

V. De Sanctis, M. Gamberini, G. Gilli, 1998, Journal of pediatric endocrinology & metabolism : JPEM.

Reply to “Hepatocellular carcinoma in thalassemia and other hemoglobinopathies”

E. Cassinerio, G. Graziadei, F. Longo, 2023, Cancer.

Exaggerated TSH response to TRH ("sub-biochemical" hypothyroidism) in prepubertal and adolescent thalassaemic patients with iron overload: prevalence and 20-year natural history.

V. De Sanctis, M. Marsella, M. Gamberini, 2008, Pediatric Endocrinology Reviews: diabetes, nutrition, metabolism.

The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies

A. Finotti, L. C. Cosenza, M. Gamberini, 2023, Biology.

Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study

R. Gambari, A. Finotti, L. C. Cosenza, 2023, Hematology reports.

patients with thalassemia major Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated

A. Cnaan, M. Cappellini, A. Piga, 2013 .

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

M. Cappellini, A. Piga, C. Borgna-Pignatti, 2004, Haematologica.

Left ventricular remodelling, and systolic and diastolic function in young adults with β thalassaemia major: a Doppler echocardiographic assessment and correlation with haematological data

G. Bosi, R. Crepaz, W. Pitscheider, 2003, Heart.

National networking in rare diseases and reduction of cardiac burden in thalassemia major.

V. Positano, A. Meloni, M. Midiri, 2021, European heart journal.

Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin)

A. Finotti, L. C. Cosenza, M. Gamberini, 2024, Journal of clinical medicine.

Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus

A. Finotti, L. C. Cosenza, M. Gamberini, 2023, International journal of molecular sciences.

Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience

Filippo Cademartiri, V. Positano, S. Mavrogeni, 2023, Tomography.

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine

A. Sundan, P. Musto, S. Lenhoff, 1995 .